Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

CVKD Cadrenal Therapeutics

Watchlist
2.829
+0.049+1.76%
Close  02/01 16:00 ET
2.900
+0.071+2.50%
Post Mkt Price 02/01 18:59 ET
High
3.160
Open
2.820
Turnover
2.66M
Low
2.750
Pre Close
2.780
Volume
907.37K
Market Cap
32.92M
P/E(TTM)
0.00
52wk High
6.750
Shares
11.63M
P/E(Static)
0.00
52wk Low
2.350
Float Cap
3.96M
Bid/Ask %
-86.67%
Historical High
6.750
Shs Float
1.40M
Volume Ratio
3.36
Historical Low
2.350
Dividend TTM
--
Div Yield TTM
--
P/B
-28.01
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
64.81%
Amplitude
14.75%
Avg Price
2.935
Lot Size
0
Float Cap
3.96M
Bid/Ask %
-86.67%
Historical High
6.750
Shs Float
1.40M
Volume Ratio
3.36
Historical Low
2.350
Dividend TTM
--
P/B
-28.01
Dividend LFY
--
Turnover Ratio
64.81%
Amplitude
14.75%
Avg Price
2.935
Lot Size
0
Price Forecast

News

Comment

Company Overview More
Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focused on developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang Pham on January 25, 2022 and is headquartered in Ponte Vedra, FL.
CEO: Mr. Quang Pham
Market: NASDAQ
Listing Date: 01/20/2023
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist